Rituximab or a second anti-tumor necrosis factor for rheumatoid arthritis patients who have failed their first antitumor necrosis factor therapy? Comparative analysis from the British Society for Rheumatology Biologics Register

1 Citations

Journal

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1570572701398967424
  • NII Article ID
    20000903377
  • Data Source
    • CiNii Articles

Report a problem

Back to top